Bicycle Therapeutics (BCYC) Non-Current Debt: 2020-2024
Historic Non-Current Debt for Bicycle Therapeutics (BCYC) over the last 3 years, with Jun 2024 value amounting to $8.5 million.
- Bicycle Therapeutics' Non-Current Debt fell 72.13% to $8.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $8.5 million, marking a year-over-year decrease of 72.13%. This contributed to the annual value of $30.7 million for FY2023, which is 1.26% up from last year.
- Per Bicycle Therapeutics' latest filing, its Non-Current Debt stood at $8.5 million for Q2 2024, which was down 72.39% from $30.8 million recorded in Q1 2024.
- Bicycle Therapeutics' Non-Current Debt's 5-year high stood at $30.8 million during Q1 2024, with a 5-year trough of $8.5 million in Q2 2024.
- Its 3-year average for Non-Current Debt is $28.2 million, with a median of $30.4 million in 2022.
- As far as peak fluctuations go, Bicycle Therapeutics' Non-Current Debt spiked by 106.23% in 2021, and later plummeted by 72.13% in 2024.
- Over the past 5 years, Bicycle Therapeutics' Non-Current Debt (Quarterly) stood at $14.5 million in 2020, then soared by 105.95% to $29.9 million in 2021, then increased by 1.48% to $30.3 million in 2022, then climbed by 1.26% to $30.7 million in 2023, then plummeted by 72.13% to $8.5 million in 2024.
- Its last three reported values are $8.5 million in Q2 2024, $30.8 million for Q1 2024, and $30.7 million during Q4 2023.